248 related articles for article (PubMed ID: 7481548)
1. Interferon-alpha 2b, with or without prior hepatic artery embolization: clinical response and survival in mid-gut carcinoid patients. The Norwegian carcinoid study.
Jacobsen MB; Hanssen LE; Kolmannskog F; Schrumpf E; Vatn MH; Bergan A
Scand J Gastroenterol; 1995 Aug; 30(8):789-96. PubMed ID: 7481548
[TBL] [Abstract][Full Text] [Related]
2. Extended experience with recombinant alpha-2b interferon with or without hepatic artery embolization in the treatment of midgut carcinoid tumours. A preliminary report.
Hanssen LE; Schrumpf E; Jacobsen MB; Kolbenstvedt AN; Kolmannskog F; Bergan A; Dolva LO
Acta Oncol; 1991; 30(4):523-7. PubMed ID: 1854510
[TBL] [Abstract][Full Text] [Related]
3. Recombinant alpha-2 interferon with or without hepatic artery embolization in the treatment of midgut carcinoid tumours. A preliminary report.
Hanssen LE; Schrumpf E; Kolbenstvedt AN; Tausjø J; Dolva LO
Acta Oncol; 1989; 28(3):439-43. PubMed ID: 2742781
[TBL] [Abstract][Full Text] [Related]
4. Treatment of malignant metastatic midgut carcinoid tumours with recombinant human alpha2b interferon with or without prior hepatic artery embolization.
Hanssen LE; Schrumpf E; Kolbenstvedt AN; Tausjø J; Dolva LO
Scand J Gastroenterol; 1989 Sep; 24(7):787-95. PubMed ID: 2477894
[TBL] [Abstract][Full Text] [Related]
5. Survival of patients with disseminated midgut carcinoid tumors after aggressive tumor reduction.
Wängberg B; Westberg G; Tylén U; Tisell L; Jansson S; Nilsson O; Johansson V; Scherstén T; Ahlman H
World J Surg; 1996 Sep; 20(7):892-9; discussion 899. PubMed ID: 8678968
[TBL] [Abstract][Full Text] [Related]
6. Hepatic artery embolotherapy of hepatic metastases from carcinoid tumors: value of using a mixture of cyanoacrylate and ethiodized oil.
Winkelbauer FW; Niederle B; Pietschmann F; Thurnher S; Wildling R; Prokesch R; Lammer J
AJR Am J Roentgenol; 1995 Aug; 165(2):323-7. PubMed ID: 7542430
[TBL] [Abstract][Full Text] [Related]
7. Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience.
Gupta S; Yao JC; Ahrar K; Wallace MJ; Morello FA; Madoff DC; Murthy R; Hicks ME; Ajani JA
Cancer J; 2003; 9(4):261-7. PubMed ID: 12967136
[TBL] [Abstract][Full Text] [Related]
8. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
[TBL] [Abstract][Full Text] [Related]
9. Hepatic artery embolisation--new approach for treatment of malignant carcinoid syndrome.
Jermendy G; Kónya A; Kárpáti P
Dtsch Z Verdau Stoffwechselkr; 1986; 46(2):130-6. PubMed ID: 2424713
[TBL] [Abstract][Full Text] [Related]
10. Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors.
Strosberg JR; Choi J; Cantor AB; Kvols LK
Cancer Control; 2006 Jan; 13(1):72-8. PubMed ID: 16508629
[TBL] [Abstract][Full Text] [Related]
11. Prolonged survival after hepatic artery embolization in patients with midgut carcinoid syndrome.
Swärd C; Johanson V; Nieveen van Dijkum E; Jansson S; Nilsson O; Wängberg B; Ahlman H; Kölby L
Br J Surg; 2009 May; 96(5):517-21. PubMed ID: 19358175
[TBL] [Abstract][Full Text] [Related]
12. Metastatic neuroendocrine hepatic tumors: resection improves survival.
Musunuru S; Chen H; Rajpal S; Stephani N; McDermott JC; Holen K; Rikkers LF; Weber SM
Arch Surg; 2006 Oct; 141(10):1000-4; discussion 1005. PubMed ID: 17043278
[TBL] [Abstract][Full Text] [Related]
13. Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours.
Kölby L; Persson G; Franzén S; Ahrén B
Br J Surg; 2003 Jun; 90(6):687-93. PubMed ID: 12808615
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter chemoembolization of progressive carcinoid liver metastasis.
Therasse E; Breittmayer F; Roche A; De Baere T; Indushekar S; Ducreux M; Lasser P; Elias D; Rougier P
Radiology; 1993 Nov; 189(2):541-7. PubMed ID: 7692465
[TBL] [Abstract][Full Text] [Related]
15. Management of disseminated midgut carcinoid tumours.
Ahlman H; Wängberg B; Jansson S; Stenqvist O; Geterud K; Tylén U; Caidahl K; Scherstén T; Tisell LE
Digestion; 1991; 49(2):78-96. PubMed ID: 1724766
[TBL] [Abstract][Full Text] [Related]
16. Hepatic artery embolization for control of symptoms, octreotide requirements, and tumor progression in metastatic carcinoid tumors.
Schell SR; Camp ER; Caridi JG; Hawkins IF
J Gastrointest Surg; 2002; 6(5):664-70. PubMed ID: 12399054
[TBL] [Abstract][Full Text] [Related]
17. Embolization of the liver in the management of metastatic carcinoid tumors.
Mårtensson H; Nobin A; Bengmark S; Lunderquist A; Owman T; Sandén G
J Surg Oncol; 1984 Nov; 27(3):152-8. PubMed ID: 6208426
[TBL] [Abstract][Full Text] [Related]
18. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of metastasized carcinoid tumor of the ileum and cecum with recombinant alpha-2b interferon].
Doberauer C; Niederle N; Kloke O; Kurschel E; Schmidt CG
Onkologie; 1987 Dec; 10(6):340-4. PubMed ID: 2450326
[TBL] [Abstract][Full Text] [Related]
20. Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases.
Hellman P; Lundström T; Ohrvall U; Eriksson B; Skogseid B; Oberg K; Tiensuu Janson E; Akerström G
World J Surg; 2002 Aug; 26(8):991-7. PubMed ID: 12016480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
